Cytokine/Antibody Fusion Protein Design and Evaluation

抗体 融合蛋白 融合 细胞因子 免疫学 医学 化学 重组DNA 生物化学 语言学 哲学 基因
作者
Charina S. Fabilane,A. Carson Stephenson,Elissa K. Leonard,Derek VanDyke,Jamie B. Spangler
出处
期刊:Current protocols [Wiley]
卷期号:4 (5)
标识
DOI:10.1002/cpz1.1061
摘要

Abstract Cytokines constitute a class of secreted proteins that activate transmembrane receptors to coordinate a vast array of physiological processes, particularly those related to immune activity. Due to their vital role in immune regulation, cytokines have garnered great interest as potential therapeutic agents. Unfortunately, the clinical success of cytokine drugs has been limited by their multifunctional activities, which hinder therapeutic performance and lead to harmful toxicities. In addition, the strikingly short circulation half‐life of cytokines further hampers their efficacy as drugs. To overcome the translational challenges associated with natural cytokines, significant efforts have focused on engineering cytokines to target their activities and improve their pharmacological properties. One such strategy is the design of fusion proteins that tether a cytokine to an anti‐cytokine antibody that selectively biases its functions and extends its serum half‐life. These cytokine/antibody fusion proteins (termed immunocytokines) assemble intramolecularly to bias cytokine signaling behavior through multi‐layered structural and molecular effects. Here, we present a detailed workflow for the design, production, and functional validation of intramolecularly assembled immunocytokines. In‐depth procedures are presented for gene manipulation, mammalian cell‐based expression and purification, binding analysis via bio‐layer interferometry, and interrogation of cytokine signaling activity on human primary cells. In contrast with immunocytokines in which the tethered cytokine and antibody do not bind one another, intramolecularly assembled immunocytokines require special considerations with respect to their production to avoid oligomerization and/or aggregation. The protocol herein was developed based on experience with immunocytokines that incorporate interleukin‐2 (IL‐2); however, this modular approach can be extended to any cytokine of interest for a broad range of biomedical applications. © 2024 Wiley Periodicals LLC. Basic Protocol 1 : Design and generation of immunocytokine genes Basic Protocol 2 : Immunocytokine expression and purification Basic Protocol 3 : Validation of immunocytokine assembly and binding by bio‐layer interferometry Basic Protocol 4 : Analysis of immunocytokine signaling on human primary cells
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
CucRuotThua完成签到,获得积分10
刚刚
单身的觅儿完成签到,获得积分10
1秒前
彭于彦祖应助忐忑的老虎采纳,获得20
5秒前
彭于晏应助zaafbb采纳,获得30
6秒前
碳酸芙兰发布了新的文献求助10
6秒前
6秒前
6秒前
无私的小鸽子完成签到,获得积分10
7秒前
Li完成签到,获得积分10
9秒前
Ava应助CucRuotThua采纳,获得10
11秒前
satchzhao完成签到,获得积分10
11秒前
77发布了新的文献求助10
12秒前
13秒前
15秒前
16秒前
msk完成签到 ,获得积分10
16秒前
忐忑的老虎完成签到,获得积分10
17秒前
DRYAN完成签到,获得积分10
17秒前
17秒前
18秒前
调研昵称发布了新的文献求助10
18秒前
一篇吃不饱应助fifteen采纳,获得10
18秒前
海阔天空发布了新的文献求助10
18秒前
111完成签到,获得积分10
19秒前
飞鸿踏雪泥完成签到 ,获得积分10
19秒前
负责蜜蜂发布了新的文献求助10
20秒前
coconut发布了新的文献求助30
21秒前
25秒前
26秒前
26秒前
29秒前
Renee应助负责蜜蜂采纳,获得10
29秒前
乐乐应助Liuu采纳,获得10
29秒前
搜集达人应助算了就这采纳,获得30
30秒前
超级瑶瑶完成签到,获得积分20
30秒前
31秒前
白翊辰完成签到,获得积分20
31秒前
烟花应助Phantom1234采纳,获得10
32秒前
丘比特应助robi采纳,获得10
32秒前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3160924
求助须知:如何正确求助?哪些是违规求助? 2812163
关于积分的说明 7894580
捐赠科研通 2471015
什么是DOI,文献DOI怎么找? 1315853
科研通“疑难数据库(出版商)”最低求助积分说明 631036
版权声明 602068